Melanie Hamilton

810 total citations · 1 hit paper
21 papers, 633 citations indexed

About

Melanie Hamilton is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Melanie Hamilton has authored 21 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 2 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Melanie Hamilton's work include Inhalation and Respiratory Drug Delivery (17 papers), Asthma and respiratory diseases (12 papers) and Respiratory and Cough-Related Research (7 papers). Melanie Hamilton is often cited by papers focused on Inhalation and Respiratory Drug Delivery (17 papers), Asthma and respiratory diseases (12 papers) and Respiratory and Cough-Related Research (7 papers). Melanie Hamilton collaborates with scholars based in United Kingdom, United States and Sweden. Melanie Hamilton's co-authors include Timothy P. Boyer, M. Zweng, Hernan E. Garcia, Ricardo Locarnini, O Baranova, Christopher R. Paver, James Reagan, Daphne R. Johnson, Dan Seidov and John I. Antonov and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and British Journal of Clinical Pharmacology.

In The Last Decade

Melanie Hamilton

20 papers receiving 620 citations

Hit Papers

World ocean atlas 2013. Volume 1, Temperature 2014 2026 2018 2022 2014 100 200 300

Peers

Melanie Hamilton
S. J. Norris United Kingdom
T. Akins United States
David Munday United Kingdom
Lei Geng China
Amy Jo Scarino United States
Mitchell V. Santander United States
Melanie Hamilton
Citations per year, relative to Melanie Hamilton Melanie Hamilton (= 1×) peers Haruka Takagi

Countries citing papers authored by Melanie Hamilton

Since Specialization
Citations

This map shows the geographic impact of Melanie Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Hamilton more than expected).

Fields of papers citing papers by Melanie Hamilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Hamilton. The network helps show where Melanie Hamilton may publish in the future.

Co-authorship network of co-authors of Melanie Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Hamilton. A scholar is included among the top collaborators of Melanie Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Hamilton. Melanie Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamilton, Melanie, et al.. (2025). Charged Particle Dynamics in Dry Powder Inhalers. Molecular Pharmaceutics. 22(9). 5485–5492.
2.
Hamilton, Melanie, et al.. (2023). In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 36(1). 34–43. 4 indexed citations
3.
Anderson, Martin, Michael Drummond, Melanie Hamilton, et al.. (2021). Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data. International Journal of COPD. Volume 16. 933–943. 16 indexed citations
4.
Cooper, Andrew, Melanie Hamilton, Mark Hammond, et al.. (2020). A cross-industry assessment of the flow rate-time profiles of test equipment typically used for dry-powder inhaler (DPI) testing: Part 1 – compendial apparatuses. Aerosol Science and Technology. 54(12). 1424–1447. 5 indexed citations
7.
Hamilton, Melanie, et al.. (2015). In Vitro Dosing Performance of the ELLIPTA ® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™). Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(6). 498–506. 46 indexed citations
8.
Prime, David, Wilfried De Backer, Melanie Hamilton, et al.. (2015). Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA ® Dry Powder Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(6). 486–497. 49 indexed citations
9.
Walker, Richard, et al.. (2015). The ELLIPTA ® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(6). 474–485. 74 indexed citations
10.
Oliver, Amanda J., et al.. (2014). Tolerability of Fluticasone Furoate/Vilanterol Combination Therapy in Children Aged 5 to 11 Years With Persistent Asthma. Clinical Therapeutics. 36(6). 928–939.e1. 15 indexed citations
11.
Locarnini, Ricardo, Alexey Mishonov, John I. Antonov, et al.. (2014). World ocean atlas 2013. Volume 1, Temperature. NOAA Institutional Repository. 313 indexed citations breakdown →
13.
Allen, Ann, et al.. (2013). Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects. British Journal of Clinical Pharmacology. 77(5). 808–820. 31 indexed citations
14.
Oliver, Amanda J., Ann Allen, Melanie Hamilton, et al.. (2013). Safety, tolerability, pharmacokinetics, and pharmacodynamics of vilanterol, a novel inhaled long‐acting β‐agonist, in children aged 5–11 years with persistent asthma: A randomized trial. Clinical Pharmacology in Drug Development. 3(3). 215–221. 13 indexed citations
15.
Oliver, Amanda J., Ann Allen, Melanie Hamilton, et al.. (2013). Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5–11 years with persistent asthma: A randomized trial. Clinical Pharmacology in Drug Development. 3(2). 144–150. 6 indexed citations
17.
Kempsford, Rodger, et al.. (2011). The safety, tolerability, pharmacodynamics and pharmacokinetics of inhaled fluticasone furoate (FF) and vilanterol (VI) are unaffected by administration in combination. European Respiratory Journal. 38(Suppl 55). p824–p824. 13 indexed citations
18.
Hamilton, Melanie, Anton M. Scheuhammer, & Niladri Basu. (2011). Mercury, selenium and neurochemical biomarkers in different brain regions of migrating common loons from Lake Erie, Canada. Ecotoxicology. 20(7). 1677–1683. 13 indexed citations
19.
Allen, Ann, et al.. (2011). The pharmacokinetics (PK) and pharmacodynamics (PD) of repeat inhaled administration of fluticasone furoate (FF) in healthy Caucasian, Chinese, Japanese and Korean subjects. 38. 3973. 1 indexed citations
20.
Schroeder, W. H., Melanie Hamilton, & Stephen R. Stobart. (1985). THE USE OF NOBLE METALS AS COLLECTION MEDIA FOR MERCURY AND ITS COMPOUNDS IN THE ATMOSPHERE. Reviews in Analytical Chemistry. 8(3). I–I. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026